We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Leo Bear-McGuinness

Science Writer

Contact Us

@LeoMcBear

Leo joined Analytical Cannabis in 2019. From research to regulations and analysis to agriculture, his writing covers all the need-to-know news for the cannabis industry. He holds a bachelor's degree in biology from Newcastle University and a master's degree in science communication from the University of Edinburgh.

Latest Content From Leo Bear-McGuinness

Analytical Cannabis August 2020 Digest

Download this free monthly resource to stay up to date with the latest developments in the cannabis industry.

VIEW

Maine to Allow Recreational Cannabis Sales From October

Nearly four years after state residents voted for recreational cannabis to be legalized, Maine regulators have set a date when commercial cannabis retail can begin.

VIEW

AOAC Extends Comment Period for Its Proposed Mycotoxin and E.coli Testing Methods

Any lab analyst with a view on how mycotoxins and E.coli bacteria should be screened for in cannabis samples has been invited to comment on AOAC International’s own drafted methods.

VIEW

After-hours Cannabis Use Has No Impact on Work Performance, Survey Finds

A new study has partly challenged the notion that cannabis can worsen a worker’s performance.

VIEW

Europe’s Largest Medical Cannabis Trial Has Begun

Project Twenty21, a two-year-long medical cannabis research project in the UK, has gone live.

VIEW

FDA Approves Epidiolex to Treat Seizures From Tuberous Sclerosis

The cannabis-derived oral spray can now be prescribed for seizures associated with tuberous sclerosis complex (TCS), a rare genetic condition that causes benign tumors to develop in different parts of the body.

VIEW

Nevada Authorities Investigate Three Dispensaries For Selling Contaminated Flower

The Nevada Cannabis Compliance Board has begun investigating three state dispensaries for selling a product that twice failed microbial testing.

VIEW

High Doses of CBD Can Help Treat Cannabis Dependence, Study Finds

According to the new study from Lancet Psychiatry, a promising treatment for cannabis dependence could be right within reach of many cannabis consumers: CBD.

VIEW

Federal Scientists Launch Hemp Program to Help Standardize Testing Methods

The scientists behind the new initiative at the National Institute of Standards and Technology also plan to help standardize the testing methods used for cannabis products, such as edibles, tinctures, and balms.

VIEW

Sapphire Medical Clinic Funds Treatment for First Medical Cannabis Patient for One Year

Sapphire Medical Clinics, one of the few medical cannabis clinics in the UK, has guaranteed the treatment of its first patient for one year.

VIEW